Marinus Pharmaceuticals, a pharmaceutical company that specialises in the development of medicines to treat rare seizure disorders, has revealed its new logo and brand identity. The new look is said to be rooted in the company’s guiding principles of “commitment, innovation and community”, which are symbolised by three interconnected rings. “The logo represents a new […]
[READ MORE]
Conran Design Group has created the logo and branding for newly founded healthcare company, Viatris. Having been born out of a pharmaceutical merger between Mylan and Pfizer’s Upjohn in late 2020, the new brand turned to Conran in search of a name and identity. The agency subsequently consulted on the brand strategy and logo development […]
[READ MORE]
Pfizer has this month unveiled a new logo and identity, which represents the first brand refresh for the pharmaceutical giant in well over half a century. The refreshed logo is constructed of two interlocking forms that are claimed to reflect unity as well as the company’s two central ideals, namely, ‘passion for science’ and the […]
[READ MORE]
European pharmaceutical company Polpharma Biologics has unveiled a new logo and corporate message as part of a rebranding initiative. The new identity reportedly comes after a year of “significant growth” at the Netherlands-headquartered company, which has brought its Utrecht research and development site, formerly Bioceros, and its Warsaw manufacturing site under the Polpharma Biologics brand, […]
[READ MORE]
Citizens United for Research in Epilepsy (CURE), the private non-profit focused on finding a cure for epilepsy, has announced the organisation’s rebrand to CURE Epilepsy. The rebrand includes a new name and logo design that is claimed to better align the brand with its stated mission. Founded in 1998 by Susan Axelrod and a small […]
[READ MORE]
U.S. cannabis company Vireo Health has announced that Minnesota Medical Solutions (MinnMed), the company’s subsidiary in the state of Minnesota, has changed its name to Vireo Health of Minnesota and its cannabis patient centres are in the process of being renovated and rebranded. The retail locations will now be called “Green Goods”. The company’s existing […]
[READ MORE]
Amabiotics, a global biotech company developing microbiome-derived medicine for neurological conditions, has announced that it is changing its corporate name to “Stellate Therapeutics”. Founded in 2010, the New York-headquartered company develops small molecules produced by human gut bacteria into what are claimed to be first-in-class personalised therapies for neurological diseases, including Parkinson’s and Alzheimer’s disease. […]
[READ MORE]
